We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Five Prime Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 147 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 147 → 0 (-147)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.56B → $0 (-$1.56B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 147

Holders
–
Holders Change
-147
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
147
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BI
BVF Inc
California
-$239M
2
BlackRock
BlackRock
New York
-$116M
3
RSCM
Rock Springs Capital Management
Maryland
-$100M
4
MF
Magnetar Financial
Illinois
-$90.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$81.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Commodore Capital
New York
– -$13.6M -361,344 Closed
Assenagon Asset Management
27
Assenagon Asset Management
Luxembourg
– -$12.9M -341,463 Closed
DAM
28
DLD Asset Management
New York
– -$11.3M -300,000 Closed
SCC
29
Spring Creek Capital
Kansas
– -$11.3M -300,000 Closed
Man Group
30
Man Group
United Kingdom
– -$11.2M -296,139 Closed
CCM
31
Chicago Capital Management
Illinois
– -$11.1M -295,864 Closed
Charles Schwab
32
Charles Schwab
California
– -$10.7M -285,058 Closed
N
33
Nuveen
North Carolina
– -$1.47M -275,753 Closed
Two Sigma Investments
34
Two Sigma Investments
New York
– -$10.3M -272,134 Closed
VI
35
Versor Investments
New York
– -$10.1M -268,019 Closed
CS
36
Credit Suisse
Switzerland
– -$9.57M -254,090 Closed
GLAM
37
Gardner Lewis Asset Management
Pennsylvania
– -$8.91M -236,565 Closed
E
38
Ergoteles
New York
– -$8.73M -231,646 Closed
KC
39
Kellner Capital
New York
– -$8.55M -226,876 Closed
GCIA
40
Gabelli & Co Investment Advisers
New York
– -$7.99M -212,054 Closed
GCL
41
Glazer Capital LLC
New York
– -$7.95M -211,079 Closed
BHMP
42
Bardin Hill Management Partners
New York
– -$7.87M -208,991 Closed
NAM
43
Nexpoint Asset Management
Texas
– -$7.47M -198,278 Closed
PCM
44
Prelude Capital Management
New York
– -$7.42M -196,905 Closed
PAMP
45
Polar Asset Management Partners
Ontario, Canada
– -$7.18M -190,641 Closed
Bank of New York Mellon
46
Bank of New York Mellon
New York
– -$7.08M -187,963 Closed
PIM
47
Platinum Investment Management
Australia
– -$6.89M -182,993 Closed
WIC
48
Water Island Capital
New York
– -$5.87M -155,703 Closed
Barclays
49
Barclays
United Kingdom
– -$5.14M -136,346 Closed
Wells Fargo
50
Wells Fargo
California
– -$5.09M -135,195 Closed
1
2
3 4 5

FPRX Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2021, worth a combined $0 — down 100% from $1.56B a quarter earlier.

Sellers outnumbered buyers: 147 funds closed out of FPRX and 0 opened new positions — a net loss of 147 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $239M sold.

  • 0 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2021, down from 147 in Q1 2021.
  • Funds reported $0 of Five Prime Therapeutics, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2021 and 147 closed out, a net change of -147 holders.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2021 was BVF Inc, an estimated $239M sold.

Based on aggregated 13F filings for Q2 2021.